Extensively drug-resistant TB (XDR-TB) is a rare type of MDR-TB that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e. amikacin, kanamycin, or capreomycin). Because XDR-TB is resistant to the most potent TB drugs, patients are left with treatment options that are much less effective. XDR-TB is of special concern for persons with HIV infection or other conditions that can weaken the immune system. These persons are more likely to develop TB disease once they are infected, and also have a higher risk of death once they develop TB.
Follow Us On Facebook
- Review and Workshop for Tuberculosis Free Nepal Campaign – 5-8-2022 – Shankar Hotel
- Strengthening Logistic Management Workshop 2079.04.11-12
- Interaction Program for Strengthening TB Laboratory System – 24th July 2022
- Meeting of the Federal Committee for Tuberculosis Free Nepal Declaration Campaign 13-07-2022
- National Strategic Plan Dissemination Program 12/07/2022